Fate Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.03.24	Fate Therapeutics Prices $100 Mln Of Public Offering, Concurrent Private Placement (RTTNews)
18.03.23	ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important March 22 Deadline in Securities Class Action - FATE (PR Newswire)
11.03.23	ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important March 22 Deadline in Securities Class Action - FATE (PR Newswire)
04.03.23	ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE (PR Newswire)
25.02.23	ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATE (PR Newswire)
18.02.23	ROSEN, A RESPECTED AND LEADING FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE (PR Newswire)
05.02.23	ROSEN, A LONGSTANDING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE (PR Newswire)
30.01.23	ROSEN, A LEADING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE (PR Newswire)
25.01.23	ROSEN, A LEADING AND RANKED FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATE (PR Newswire)
06.01.23	Pre-market Movers: SPRB, HKD, CTMX, FATE, ELOX… (RTTNews)
08.12.20	BLCM Hit With Clinical Hold, LANTERN Fails To Light Up LYRA, TNXP Gains, FDA Says No To SCPH (RTTNews)
03.12.20	BCRX Awaits FDA Decision, JNJ On Watch, Pfizer/BioNTech's COVID-19 Vaccine Gets Green Light In UK (RTTNews)
10.06.20	DNLI Halts DNL747 Development, IMRN Skyrockets, XENT's Sinus Implant Gets New C-Code (RTTNews)
03.04.20	Stock Alert: Fate Therapeutics Stock Up 21% In Pre-Market (RTTNews)
03.04.20	Fate Therapeutics Seals Deal With JNJ For Cancer Immunotherapies, Stock Jumps (RTTNews)
10.12.19	Top Gainers: THOR Acquired, FTSV Up On Magrolimab Data, Investors Believe FATE (RTTNews)
26.10.18	FATE Catches Eyes, LJPC Upbeat, CLSD To Submit XIPERE NDA By Year-end (RTTNews)
12.04.18	CBAY Walks The Talk, MYND Explodes, NITE Sparkles, NVLN Awaits CHMP Opinion (RTTNews)
22.02.18	ANTH Awaits RESULT In Mar., HAIR Grows, NITE Shines, TRXC On Must-watch List (RTTNews)
29.12.17	CERC Down But Not Out, EYEG To Report Data In Q2, MRSN On Watch (RTTNews)
27.12.17	Busy Year Awaits INSY, Agile Not So Energetic, FATE Gathers Steam, SRRA On Watch (RTTNews)
22.12.17	APLS Sets Out Its Vision, APEN Gains Weight, Packed Year Ahead For DRNA (RTTNews)
05.12.17	ASH: BPMC To Make A Mark; FATE So Far, So Good; Watch Out For SYRS, BIVV (RTTNews)
30.08.17	ACHV Focuses On Achievement, IMGN Strikes Chord With JAZZ, FDA Snubs ACOR (RTTNews)
15.08.17	FDA Lifts Hold On CVM's Study, FATE On Track, REGN, OPHT, ZYNE All Flunk Trials (RTTNews)
22.02.16	FDA Expands Use Of Pfizer's Ibrance, Attack On Titan, Spectrum Gets FDA Date (RTTNews)
27.01.16	FATE Gets Attention, IMGN Earns Milestone Payment, KIN Gains Weight (RTTNews)
21.05.15	Fate Therapeutics Prices Public Offering Of 6 Mln Shares At $5.00 Per Share (RTTNews)
07.05.15	ANAC, TTPH Await Data In Q3, FATE Makes Gains, CBPO Sees Good Times Ahead (RTTNews)
06.05.15	Pre-market Movers For May 6 (WEN, CHK, MGI, WU, WD, GEVA, ALXN, BRDR, FATE, ZU) (RTTNews)
12.11.14	SUPN Revises Revenue Outlook Upward, EVDY Fit And Fine, NASDAQ Warning For ACST (RTTNews)
30.07.14	ADMP Awaits Decision, REGN Can Catch Your Eye, SQNM Does A Deal, ZLTQ Goes Cool (RTTNews)
17.03.14	Fate Therapeutics Q4 Loss Widens - Quick Facts (RTTNews)
12.03.14	Fate Therapeutics Begins Phase 2 Study Of PROHEMA For Hematologic Malignancies (RTTNews)
26.02.14	Fate Therapeutics: DmPGE2 Improves Functional Properties Of T Cells (RTTNews)
01.10.13	Fate Therapeutics Prices IPO At $6.00/shr, Low End Of Revised Range (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Fate Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten